from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0467/icl1

LFCtreatmentdescriptionclass of inhibitor

0.879

Amikacinug/mL Amikacintranslation

0.320

Cap5-10ug/mL Capreomycintranslation

0.667

Rox10-50 ug/mL Roxithromycintranslation

0.707

SM2-5 ug/mL Streptomycintranslation

0.653

Tet5-10 ug/mL Tetracyclinetranslation

-0.437

Rif0.2-5ug/mL Rifampicintranscription

-0.072

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.006

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.961

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.082

CPZ10-50 ug/mL Chlorpromazinerespiration

1.346

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.036

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.774

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.011

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.993

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.183

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.434

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.068

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.014

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.819

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.615

KCN5-20 ug/mL Potassium cyaniderespiration

0.580

NaN30.2-2 mM Sodium aziderespiration

-0.394

Nigericin50 uM Nigericinrespiration

0.193

TRC10-150 ug/mL Triclosanrespiration

0.335

TRZ10-25 ug/mL Thioridazinerespiration

1.003

Valinomycin0.5-10 uM Valinomycinrespiration

-0.742

ZnSO42 mM ZnSO4respiration

0.891

menadione6-10 ug/mL Menadionerespiration

1.320

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.305

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.788

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.567

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.109

NRP_1Non-replicating persistence stage 1dosRassociated

-0.417

Amp0.2mg/mL AmpicillincellWall

-0.268

Cephalexin20-100 ug/mL CephalexincellWall

0.235

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.299

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.352

EMB10-20 ug/mL EthambutolcellWall

0.859

Eta12-40 ug/mL EthionamidecellWall

0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

0.719

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.327

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.591

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.772

BZA0.12 mg/mL BenzamidearomaticAmides

-1.913

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.596

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.127

H2O24 mM hydrogen peroxideDNAdamaging

-0.708

Levo10 ug/mL LevofloxacinDNAdamaging

-0.183

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.092

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.277

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.173

UVUV-irradiationDNAdamaging

0.411

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.383

Antimycin12.5-50 ug/mL Antimycin A?

-0.601

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.498

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.386

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.295

PA8240.2-2 ug/mL PA-824?

2.180

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.344

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.511

Verapamil50 uM Verapamil?

-0.330

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.341

methoxatin10-20 ug/mL Methoxatin?